Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.03, versus $0.10 reported last year. Revenue for the quarter came in at $8.04 million, versus $9.33 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.